ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HLN Haleon Plc

334.40
2.90 (0.87%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Haleon Plc LSE:HLN London Ordinary Share GB00BMX86B70 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.90 0.87% 334.40 334.70 334.80 336.00 330.80 332.70 24,166,169 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices-holdng Companies,nec 11.3B 1.05B 0.1136 29.47 30.92B

Haleon PLC Holding(s) in Company (6001Z)

16/05/2023 2:00pm

UK Regulatory


Haleon (LSE:HLN)
Historical Stock Chart


From Apr 2023 to Apr 2024

Click Here for more Haleon Charts.

TIDMHLN

RNS Number : 6001Z

Haleon PLC

16 May 2023

16 May 2023

HALEON PLC

("Haleon" or "the Company")

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMX86B70

Issuer Name

Haleon plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Glaxo Group Limited

City of registered office (if applicable)

Brentford

Country of registered office (if applicable)

United Kingdom

 
  Name                                 City of registered office    Country of registered office 
   GlaxoSmithKline Holdings Limited     Brentford                    England 
                                     ===========================  ============================== 
   GlaxoSmithKline Finance plc          Brentford                    England 
                                     ===========================  ============================== 
 

4. Details of the shareholder

 
  Name                         City of registered office    Country of registered office 
   Vidacos Nominees Limited     London                       England 
                             ===========================  ============================== 
 

5. Date on which the threshold was crossed or reached

12-May-2023

6. Date on which Issuer notified

15-May-2023

7. Total positions of person(s) subject to the notification obligation

 
                          % of voting rights      % of voting rights      Total of both in %      Total number of 
                          attached to shares      through financial       (8.A + 8.B)             voting rights held 
                          (total of 8.A)          instruments (total                              in issuer 
                                                  of 8.B 1 + 8.B 2) 
   Resulting situation 
    on the date on 
    which threshold 
    was crossed or 
    reached                2.850000                0.000000                2.850000                262727073 
                        ======================  ======================  ======================  ====================== 
   Position of 
    previous 
    notification (if 
    applicable)            5.440000                0.000000                5.440000 
                        ======================  ======================  ======================  ====================== 
 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

 
Class/Type of shares    Number of direct        Number of indirect      % of direct voting      % of indirect voting 
ISIN code(if possible)  voting rights (DTR5.1)  voting rights           rights (DTR5.1)         rights (DTR5.2.1) 
                                                (DTR5.2.1) 
GB00BMX86B70               262727073                                       2.850000 
                        ======================  ======================  ======================  ====================== 
Sub Total 8.A              262727073                                       2.850000% 
                        ==============================================  ============================================== 
 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 
Type of financial           Expiration date  Exercise/conversion period  Number of voting rights    % of voting rights 
instrument                                                               that may be acquired if 
                                                                         the instrument is 
                                                                         exercised/converted 
 
Sub Total 8.B1 
                            ===========================================  =========================  ================== 
 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 
Type of financial   Expiration date  Exercise/conversion  Physical or cash     Number of voting     % of voting rights 
instrument                           period               settlement           rights 
 
Sub Total 8.B2 
                    =========================================================  ===================  ================== 
 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

 
Ultimate controlling     Name of controlled       % of voting rights if  % of voting rights     Total of both if it 
person                   undertaking              it equals or is        through financial      equals or is higher 
                                                  higher than the        instruments if it      than the notifiable 
                                                  notifiable threshold   equals or is higher    threshold 
                                                                         than the notifiable 
                                                                         threshold 
   GSK plc                                           2.850000                                      2.850000% 
                                                  =====================  =====================  ====================== 
                            GlaxoSmithKline 
   GSK plc                   Holdings Limited        2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
                            GlaxoSmithKline 
   GSK plc                   Finance plc             2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
   GSK plc                  Glaxo Group Limited      2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

GSK plc is making this notification on behalf of Glaxo Group Limited, GlaxoSmithKline Finance plc and GlaxoSmithKline Holdings Limited.

This notification relates to the sale by Glaxo Group Limited (a wholly-owned subsidiary of GSK plc and the holder of other external minority interests of the GSK group) of a portion of its interest in Haleon plc. A separate notification has also been submitted today by GSK plc in respect of its own notification obligation.

Glaxo Group Limited holds its shares in Haleon plc via a custodian, Vidacos Nominees Limited (as detailed in section 4 above), which holds the legal title to those shares on Glaxo Group Limited's behalf pursuant to a custody arrangement.

12. Date of Completion

15-May-2023

13. Place Of Completion

London, England

Amanda Mellor, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUNRAROOUVAAR

(END) Dow Jones Newswires

May 16, 2023 09:00 ET (13:00 GMT)

1 Year Haleon Chart

1 Year Haleon Chart

1 Month Haleon Chart

1 Month Haleon Chart

Your Recent History

Delayed Upgrade Clock